Showing results (1-10 of 151) with videos related to
Sort By:
Pageof 16
Haematologica|February 12, 2026
Intrinsic cellular resistance to BCR::ABL1 inhibitorsNataly Cruz-Rodriguez, Yulieth Torres-Llanos, Michael W DeiningerBlood|December 27, 2024
Novel treatment strategies for chronic myeloid leukemiaNataly Cruz-Rodriguez, Michael W DeiningerFrontiers in Immunology|December 16, 2024
ID1 and ID3 functions in the modulation of the tumour immune microenvironment in adult patients with B-cell acute lymphoblastic leukaemiaNathaly Poveda-Garavito, Carlos A Orozco Castaño, Yulieth Torres-Llanos, et al.Frontiers in Molecular Biosciences|May 15, 2024
MIR4435-2HG as a possible novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALLYulieth Torres-Llanos, Jovanny Zabaleta, Nataly Cruz-Rodriguez, et al.Haematologica|February 26, 2026
Exploiting metabolic dependencies in acute myeloid leukemia: DHODH inhibition meets lipid and cholesterol metabolismNataly Cruz-RodriguezHaematologica|April 16, 2026
RBM15 and ZMYND8 shape acute myeloid leukemia response to BCL2 inhibitorsNataly Cruz-RodriguezMethods in Molecular Biology (Clifton, N.J.)|September 5, 2018
Epigenetics in Hematological MalignanciesNataly Cruz-Rodriguez, Alba L Combita, Jovanny ZabaletaHematology. American Society of Hematology. Education Program|December 17, 2008
Milestones and monitoring in patients with CML treated with imatinibMichael W DeiningerHematology. American Society of Hematology. Education Program|December 6, 2015
Molecular monitoring in CML and the prospects for treatment-free remissionsMichael W DeiningerAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Diagnosing and managing advanced chronic myeloid leukemiaMichael W DeiningerPageof 16